|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 10.42 USD | -1.79% |
|
-2.98% | +164.47% |
| 09-20 | Turn Therapeutics Inc.(NasdaqGM:TTRX) added to S&P TMI Index | CI |
| 09-09 | Turn Therapeutics Inc. Announces Appointment of Robert R. Redfield as Chief Scientific Officer | CI |
| Market Cap | 316M 284M 262M 238M 444M 30.06B 450M 3.14B 1.25B 15.75B 1.19B 1.16B 49.93B | P/E 2026 * |
-22.7x | P/E 2027 * | -23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 316M 284M 262M 238M 444M 30.06B 450M 3.14B 1.25B 15.75B 1.19B 1.16B 49.93B | EV / Sales 2026 * |
1,264x | EV / Sales 2027 * | 126x |
| Free-Float |
47.1% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TTRX | Delayed | |
CBOE
| TTRX | Real-time |
| 1 day | -1.79% | ||
| 1 week | -2.98% | ||
| Current month | -27.59% | ||
| 1 month | -16.57% | ||
| 3 months | +22.01% | ||
| 6 months | +193.94% | ||
| Current year | +164.47% |
| 1 week | 9.83 |  | 10.83 |
| 1 month | 9.83 | | 14.63 |
| Current year | 3.01 | | 16.45 |
| 1 year | 2.57 | | 16.45 |
| 3 years | 2.57 | | 26.5 |
| 5 years | 2.57 | | 26.5 |
| 10 years | 2.57 | | 26.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bradley Burnam
CEO | Chief Executive Officer | 48 | 2018-09-30 |
Zuraiz Chaudhary
DFI | Director of Finance/CFO | 31 | 2025-04-30 |
Stephen Hahn
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bradley Burnam
CHM | Chairman | 48 | - |
| Director/Board Member | 47 | 2018-09-30 | |
Andrew Gengos
BRD | Director/Board Member | 62 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/28/26 | Don | Chief Executive Officer | -1,200,000 | 4.0285% | ||
| 4/2/26 | Don | Chief Executive Officer | 300,000 | 1.0188% | ||
| 4/2/26 | Don | Director | 300,000 | 1.0188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | -2.98% | +105.12% | - | 316M | |
| -3.10% | -3.43% | +36.29% | +67.69% | 65.28B | |
| +0.33% | +7.26% | +11.51% | +77.95% | 54.57B | |
| +0.16% | +3.69% | +8.39% | +101.27% | 53.59B | |
| -0.75% | +2.13% | +23.14% | +47.25% | 45.03B | |
| -1.30% | -1.11% | +17.77% | +120.71% | 42.17B | |
| +1.26% | +2.23% | +241.81% | +835.31% | 39.42B | |
| -0.74% | -4.84% | +14.53% | +44.45% | 32.71B | |
| -2.70% | -7.34% | +23.17% | +0.36% | 24.01B | |
| +1.11% | +17.90% | +56.87% | +47.78% | 26.5B | |
| Average | -0.75% | +1.66% | +53.86% | +149.20% | 38.36B | |
| Weighted average by Cap. | -0.72% | +1.72% | +45.21% | +148.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 250K 225K 207K 188K 351K 23.78M 356K 2.49M 988K 12.46M 938K 918K 39.49M | 2.5M 2.25M 2.07M 1.88M 3.51M 238M 3.56M 24.87M 9.88M 125M 9.38M 9.18M 395M |
| Net income | -15.5M -13.93M -12.85M -11.65M -21.78M -1.47B -22.05M -154M -61.25M -772M -58.18M -56.93M -2.45B | -23M -20.67M -19.06M -17.29M -32.31M -2.19B -32.72M -229M -90.88M -1.15B -86.33M -84.48M -3.63B |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | US$10.42 | -1.79% | 98,414 |
| 26-10-26 | US$10.61 | +3.21% | 98,176 |
| 26-10-23 | US$10.28 | +0.98% | 87,049 |
| 26-10-22 | US$10.18 | +0.30% | 113,120 |
| 26-10-21 | US$10.15 | -3.06% | 60,584 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.42USD
Average target price
25.00USD
Spread / Average Target
+139.92%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TTRX Stock
Select your edition
All financial news and data tailored to specific country editions
